Chemex Pharmaceuticals Inc. regulatory update

The Fort Lee, N.J., company said it will refile its NDA in April 1995 for Amlexanox to treat aphthous ulcers (canker sores) because its bulk drug manufacturer is being renovated and its facility will not be available for the mandatory FDA inspection until April 1. CHMX is developing the drug in a joint venture with Block Drug Co. ...